The UK’s Medicines and Healthcare products Regulatory Agency has announced ambitious new plans to overhaul its clinical trials system.
Over the next two years, it intends to deliver several projects to drive the uptake of innovative trial designs, patient focused outcome measures, data-enabled recruitment and real-world evidence collection and analysis
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?